• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

A mechanism for the specific immunogenicity of heat shock protein-chaperoned peptides.

作者信息

Suto R, Srivastava P K

机构信息

Department of Biological Sciences, Fordham University, Bronx, NY 10458, USA.

出版信息

Science. 1995 Sep 15;269(5230):1585-8. doi: 10.1126/science.7545313.

DOI:10.1126/science.7545313
PMID:7545313
Abstract

Endogenously synthesized antigenic determinants are generally presented on major histocompatibility complex (MHC) class I molecules, whereas exogenous determinants are presented by MHC class II molecules. Here, it is shown that exogenous antigens chaperoned by a heat shock protein can be channeled into the endogenous pathway, presented by MHC class I molecules, and recognized by CD8+ T lymphocytes. This pathway is functional only in a subset of macrophages among the cell types tested. These observations provide a basis for the tumor-specific and virus-specific immunogenicity of cognate heat shock protein preparations and offer a mechanism for the classical phenomenon of cross-priming.

摘要

相似文献

1
A mechanism for the specific immunogenicity of heat shock protein-chaperoned peptides.
Science. 1995 Sep 15;269(5230):1585-8. doi: 10.1126/science.7545313.
2
Leucine aminopeptidase is not essential for trimming peptides in the cytosol or generating epitopes for MHC class I antigen presentation.亮氨酸氨肽酶对于在细胞质中修剪肽段或产生用于MHC I类抗原呈递的表位并非必不可少。
J Immunol. 2005 Nov 15;175(10):6605-14. doi: 10.4049/jimmunol.175.10.6605.
3
Heat shock protein-chaperoned peptides but not free peptides introduced into the cytosol are presented efficiently by major histocompatibility complex I molecules.热休克蛋白伴侣肽而非引入胞质溶胶的游离肽能被主要组织相容性复合体I分子有效呈递。
J Biol Chem. 2001 May 18;276(20):17163-71. doi: 10.1074/jbc.M011547200. Epub 2001 Mar 8.
4
An endogenous antigenic peptide bypasses the class I antigen presentation defect in RMA-S.一种内源性抗原肽绕过了RMA-S细胞中的I类抗原呈递缺陷。
J Exp Med. 1992 Mar 1;175(3):719-29. doi: 10.1084/jem.175.3.719.
5
IFN-gamma-induced recognition of the antigen-processing variant CMT.64 by cytolytic T cells can be replaced by sequential addition of beta 2 microglobulin and antigenic peptides.γ干扰素诱导的细胞毒性T细胞对抗原加工变体CMT.64的识别可通过依次添加β2微球蛋白和抗原肽来替代。
J Immunol. 1993 Sep 15;151(6):2974-85.
6
Beta 2-microglobulin independent presentation of exogenously added foreign peptide and endogenous self-epitope by MHC class I alpha-chain to a cross-reactive CD8+ CTL clone.MHC I类α链将外源性添加的外源肽和内源性自身表位独立呈递给交叉反应性CD8⁺CTL克隆,而不依赖β2-微球蛋白。
J Immunol. 1994 Nov 1;153(9):4070-80.
7
Presentation of viral antigens restricted by H-2Kb, Db or Kd in proteasome subunit LMP2- and LMP7-deficient cells.蛋白酶体亚基LMP2和LMP7缺陷细胞中受H-2Kb、Db或Kd限制的病毒抗原呈递
Eur J Immunol. 1994 Aug;24(8):1863-8. doi: 10.1002/eji.1830240822.
8
Heat shock protein-peptide complexes, reconstituted in vitro, elicit peptide-specific cytotoxic T lymphocyte response and tumor immunity.体外重构的热休克蛋白-肽复合物可引发肽特异性细胞毒性T淋巴细胞反应和肿瘤免疫。
J Exp Med. 1997 Oct 20;186(8):1315-22. doi: 10.1084/jem.186.8.1315.
9
Bacterial heat shock proteins promote CD91-dependent class I MHC cross-presentation of chaperoned peptide to CD8+ T cells by cytosolic mechanisms in dendritic cells versus vacuolar mechanisms in macrophages.细菌热休克蛋白通过树突状细胞中的胞质机制与巨噬细胞中的液泡机制,促进伴侣肽的CD91依赖性I类主要组织相容性复合体交叉呈递给CD8 + T细胞。
J Immunol. 2004 May 1;172(9):5277-86. doi: 10.4049/jimmunol.172.9.5277.
10
Peptide-priming of cytolytic T cell immunity in vivo using beta 2-microglobulin as an adjuvant.使用β2微球蛋白作为佐剂在体内对细胞溶解性T细胞免疫进行肽启动。
J Immunol. 1993 Feb 15;150(4):1244-52.

引用本文的文献

1
Beneficial Handling of Molecular Chaperones (Chaperonotherapy) in Glioblastoma and Neuroblastoma: Novel Therapeutic Targets or Potential Agents?胶质母细胞瘤和神经母细胞瘤中分子伴侣的有益处理(伴侣疗法):新型治疗靶点还是潜在药物?
Cells. 2025 Sep 16;14(18):1447. doi: 10.3390/cells14181447.
2
A new weapon: the application of tumor vaccines based on extracellular exosomal heat shock proteins in immunotherapy.一种新武器:基于细胞外外泌体热休克蛋白的肿瘤疫苗在免疫治疗中的应用。
Front Immunol. 2025 Jan 22;16:1510650. doi: 10.3389/fimmu.2025.1510650. eCollection 2025.
3
APAVAC Immunotherapy for the Adjuvant Treatment of a Canine Mucosal Melanoma.
APAVAC免疫疗法用于犬黏膜黑色素瘤的辅助治疗。
Vet Sci. 2024 Dec 6;11(12):628. doi: 10.3390/vetsci11120628.
4
Nanoparticle-Based Drug Delivery Systems in Inhaled Therapy: Improving Respiratory Medicine.吸入疗法中基于纳米颗粒的药物递送系统:改善呼吸医学。
Pharmaceuticals (Basel). 2024 Aug 12;17(8):1059. doi: 10.3390/ph17081059.
5
Tumor Dormancy and Reactivation: The Role of Heat Shock Proteins.肿瘤休眠与再激活:热休克蛋白的作用。
Cells. 2024 Jun 23;13(13):1087. doi: 10.3390/cells13131087.
6
AutoEpiCollect, a Novel Machine Learning-Based GUI Software for Vaccine Design: Application to Pan-Cancer Vaccine Design Targeting PIK3CA Neoantigens.AutoEpiCollect,一种用于疫苗设计的新型基于机器学习的图形用户界面软件:在针对PIK3CA新抗原的泛癌疫苗设计中的应用。
Bioengineering (Basel). 2024 Mar 27;11(4):322. doi: 10.3390/bioengineering11040322.
7
Relief of tumor hypoxia using a nanoenzyme amplifies NIR-II photoacoustic-guided photothermal therapy.使用纳米酶缓解肿瘤缺氧可增强近红外二区光声引导的光热疗法。
Biomed Opt Express. 2023 Dec 6;15(1):59-76. doi: 10.1364/BOE.499286. eCollection 2024 Jan 1.
8
"All for One and One for All": The Secreted Heat Shock Protein gp96-Ig Based Vaccines.“众志成城”:分泌热休克蛋白 gp96-Ig 的疫苗。
Cells. 2023 Dec 29;13(1):72. doi: 10.3390/cells13010072.
9
GPC3 and PEG10 peptides associated with placental gp96 elicit specific T cell immunity against hepatocellular carcinoma.GPC3 和 PEG10 肽与胎盘 gp96 相关,可引发针对肝细胞癌的特异性 T 细胞免疫。
Cancer Immunol Immunother. 2023 Dec;72(12):4337-4354. doi: 10.1007/s00262-023-03569-2. Epub 2023 Nov 6.
10
Tumor-repopulating cell-derived microparticles elicit cascade amplification of chemotherapy-induced antitumor immunity to boost anti-PD-1 therapy.肿瘤再生细胞衍生的微粒体引发化疗诱导的抗肿瘤免疫级联放大,以增强抗 PD-1 治疗。
Signal Transduct Target Ther. 2023 Oct 25;8(1):408. doi: 10.1038/s41392-023-01658-3.